Skip to content

To see the effect of Shunthyadya Ghrita Nasya and Shirashooladivajra ras orally in Ardhavabhedaka (Migraine)

Comparative Clinical Evaluation of Shunthyadya Ghrita Nasya and Shirashooladivajra ras orally in Ardhavabhedaka (Migraine) - NIL

Status
Active, not recruiting
Phases
Phase 1Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/06/054522
Enrollment
60
Registered
2023-06-28
Start date
Unknown
Completion date
Unknown
Last updated
2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G431- Migraine with aura Health Condition 2: G430- Migraine without aura

Interventions

None listed

Sponsors

Patanjali Bhartiya Ayurvigyan Evam Anusandhan Sansthan
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients with classical signs & symptoms of Ardhavabhedaka (Migraine) described as per ayurvedic and modern science. 2. Patients between the age group of 18 years to 50 years of either sex. 3. Patients in related group who are fit for Nasya Karma Nasya yogya vyakti.

Exclusion criteria

Exclusion criteria: 1. Patients less than 18 years and above 50 years of age. 2. Patients who are contraindicated for Nasya Karma. 3. Patients suffering from any other forms of headaches apart from Ardhavabhedaka (Migraine) like headaches arising due to HTN, sinusitis, meningitis, encephalitis and ocular manifestations. 4. Patient suffering from any systemic diseases like diabetes mellitus, heart disease, hypertension, cancer and receiving medication which may alter the results of study.

Design outcomes

Primary

MeasureTime frame
Assessment will be made on the basis of Subjective parameters: 1. Severity of Headache. 2. Frequency of Headache. 3. Duration of Headache. 4. Nausea. 5. Vomiting. 6. Vertigo. 7. Aura. 8. Photophobia. 9. Phonophobia.Timepoint: 0, 8 weeks, 10 weeks, 12 weeks

Secondary

MeasureTime frame
Subjective parameters: 1. Severity of Headache. 2. Frequency of Headache. 3. Duration of Headache. 4. Nausea. 5. Vomiting. 6. Vertigo. 7. Aura. 8. Photophobia. 9. Phonophobia.Timepoint: 0,8 weeks, 10 weeks, 12 weeks.

Countries

India

Contacts

Public ContactSangyasri negi

Patanjali Bhartiya Ayurvigyan Evam Anusandhan Sansthan

dranilverma11@gmail.com9897298775

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026